Faraday Pharmaceuticals Funding: $63M Raised, Series A

Faraday Pharmaceuticals is based in Seattle, WA. It has raised $63M in total funding. Latest round: Series A. Backed by ARCH Venture Partners, Polaris.

Faraday Pharmaceuticals funding overview

Faraday Pharmaceuticals is based in Seattle, WA. Faraday Pharmaceuticals has raised $63M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2019. The round record for Faraday Pharmaceuticals runs through 2019; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Polaris. 2 distinct backers are named across the disclosed rounds.

Faraday Pharmaceuticals at a glance

Total raised
$63M
Latest round
Series A
Latest round date
January 2019
Headquarters
Seattle, WA
Notable investors
ARCH Venture Partners, Polaris

Frequently asked about Faraday Pharmaceuticals funding

How much has Faraday Pharmaceuticals raised?
Faraday Pharmaceuticals has raised $63M in total disclosed funding across the rounds on record.
Who has invested in Faraday Pharmaceuticals?
ARCH Venture Partners, Polaris are named among the investors backing Faraday Pharmaceuticals.
What was the latest Faraday Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in January 2019.
Where is Faraday Pharmaceuticals based?
Faraday Pharmaceuticals is based in Seattle, WA.
When did Faraday Pharmaceuticals last raise?
The last disclosed Faraday Pharmaceuticals round closed in January 2019 at Series A.

Faraday Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Seattle below to benchmark round size and investor mix.

Companies related to Faraday Pharmaceuticals (35)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026